Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant CD74 anticorps

Cet anticorps anti-CD74 est un anticorps Lapin Chimeric détectant CD74 dans FACS, WB, IP et RIA. Adapté pour Humain.
N° du produit ABIN7072683

Aperçu rapide pour Recombinant CD74 anticorps (ABIN7072683)

Antigène

Voir toutes CD74 Anticorps
CD74 (HLA-DR-gamma (CD74))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 209
  • 79
  • 20
  • 14
Humain

Hôte

  • 133
  • 95
  • 4
  • 3
  • 2
Lapin

Clonalité

  • 162
  • 72
  • 2
Chimeric

Conjugué

  • 77
  • 18
  • 16
  • 11
  • 9
  • 8
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
Cet anticorp CD74 est non-conjugé

Application

  • 137
  • 135
  • 84
  • 51
  • 41
  • 36
  • 31
  • 28
  • 14
  • 13
  • 13
  • 11
  • 11
  • 10
  • 4
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Western Blotting (WB), Immunoprecipitation (IP), Radioimmunoassay (RIA)

Clone

LL1 (EPB1)
  • Fonction

    Anti-CD74 [LL1 (EPB1)], Rabbit IgG, kappa

    Specificité

    This antibody reacts with the cell surface epitope of the invariant chain (Ii) subunit of the immatrue MHC class-II antigen CD74.

    Attributs du produit

    Original Species of Ab: Mouse

    Original Format of Ab: IgG1

    Purification

    Protein A affinity purified

    Immunogène

    This antibody was generated by immunizing female BALB/c mice with whole Raji cells or a crude membrane preparation.

    Isotype

    IgG kappa
  • Indications d'application

    Radioimmunobinding and flow cytometric analysis was used to analyse binding of LL1 to peripheral blood. LL1 did not react with T cell lines nor with normal diploid cells. The reactivity of LL1 (EB-1) to the tumor cells was checked using a live cell indirect immunoflurescence staining assay. LL1 stained positive for cell lines Raji (maxilla), Daudi (B-lymphoblast), RAMOS (b-lymphocyte), SU-DHL-7, ARH-77 (plasma cell leukemia), HS-Sultan (plasmacytoma). LL1 is reported to recognize most of the small and large lymphocytes of the germinal centre and no reactivity to marginal zone B-cells. It is also reported to react with interdigitating histiocytes of the T-cell zones. It was further reported that LL1 bound positively to Western blotted Raji cell antigens (PMID: 2663143). The specificity of LL1 for Ii subunit was determined by immunoprecipitation. Radiolabelled antibodies were used for internalization and catabolism of the antibody and it was seen that LL1 was internalized and catabolized very quickly as compared to some other antibodies like those which are specific for CD19, CD22 and anti-transferrin receptor. (PMID: 8947500). LL1 was evaluated to be a potential candidate for bone marrow imaging using Tcm labelled LL1 sulphur colloid imaging. (PMID: 9076770)

    Commentaires

    This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques.

    Restrictions

    For Research Use only
  • Concentration

    1 mg/mL

    Buffer

    PBS with 0.02 % Proclin 300.

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Antigène

    CD74 (HLA-DR-gamma (CD74))

    Autre désignation

    CD74

    Sujet

    Ii, p33, DHLAG, HLADG, Ia-GAMMAHLA, HLA Class II histocompatibility antigen gamma chain, HLA-DR antigens-associated invariant chain, Ia antigen-associated invariant chain,

    UniProt

    P04233

    Pathways

    Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Negative Regulation of intrinsic apoptotic Signaling, Cancer Immune Checkpoints
Vous êtes ici:
Chat with us!